BIOMARIN PHARMACEUTICAL INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 17,773,281 | $1,256,393,234 | 1.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 15,772,173 | $866,996,351 | 0.69% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 11, 2025 |
| Sept. 30, 2025 | 15,229,287 | $824,818,238 | 0.63% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 14,549,314 | $864,665,732 | 0.65% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 14,194,005 | $801,819,344 | 0.63% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 14,190,183 | $811,962,329 | 0.48% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.